Literature DB >> 15355327

3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone.

Sahruh Turkmen1, Per Lundgren, Vita Birzniece, Elisabeth Zingmark, Torbjorn Backstrom, Inga-Maj Johansson.   

Abstract

Allopregnanolone is a progesterone metabolite and GABA-A receptor modulator with benzodiazepine like effects, including decreased learning and memory. In vitro 3beta-hydroxypregnane steroids antagonize allopregnanolone-induced effects, but no antagonism has been shown in vivo. Our purpose was to evaluate 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) as a blocker of allopregnanolone-induced effects in vivo and in vitro in rats. We tested adult male Wistar rats in the Morris water maze 8 min after daily injections (i.v.) of allopregnanolone 2 mg/kg (n = 21); allopregnanolone : UC1011 2 : 6 (n = 7), 2 : 8 (n = 7), 2 : 20 (n = 14) mg/kg; UC1011 20 mg/kg (n = 14); or vehicle (10% 2-hydroxypropyl-beta-cyclodextrin, n = 4). Studies of chloride ion uptake into cortical and hippocampal membrane preparations were performed. The latency to find the hidden platform was still high in the allopregnanolone-injected group on day 6. Day 3-6 rats injected with allopregnanolone and UC1011 (2 : 20 mg/kg) had lower latency (P < 0.05), compared to the allopregnanolone-injected group. The group that only received UC1011 learned the location of the platform as fast as the controls. There was no significant difference in swim speed between groups. The time spent swimming close to the pool wall was in the allopregnanolone : UC1011 group (2 : 20 mg/kg) significantly decreased (P < 0.05, day 3-6), compared to the allopregnanolone-injected group. The increased chloride ion uptake induced by increasing dosage of allopregnanolone in the presence of 10 micro m GABA was significantly decreased with UC1011 (P < 0.01), in both cortical and hippocampal homogenates. In conclusion, UC1011 can via antagonism at the GABA-A receptor reduce the negative allopregnanolone effect on learning in the water maze.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355327     DOI: 10.1111/j.1460-9568.2004.03610.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats.

Authors:  Olivier George; Monique Vallée; Sergio Vitiello; Michel Le Moal; Pier-Vincenzo Piazza; Willy Mayo
Journal:  Biol Psychiatry       Date:  2010-05-14       Impact factor: 13.382

Review 2.  Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes.

Authors:  Olivier George; Monique Vallée; Michel Le Moal; Willy Mayo
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

3.  Pharmacokinetic and behavioral effects of allopregnanolone in healthy women.

Authors:  Erika Timby; Matts Balgård; Sigrid Nyberg; Olav Spigset; Agneta Andersson; Joanna Porankiewicz-Asplund; Robert H Purdy; Di Zhu; Torbjörn Bäckström; Inger Sundström Poromaa
Journal:  Psychopharmacology (Berl)       Date:  2005-09-21       Impact factor: 4.530

4.  β2-AR-HIF-1α: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis.

Authors:  T Shan; J Ma; Q Ma; K Guo; J Guo; X Li; W Li; J Liu; C Huang; F Wang; E Wu
Journal:  Curr Mol Med       Date:  2013-07       Impact factor: 2.222

5.  Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.

Authors:  Erika Timby; Torbjörn Bäckström; Sigrid Nyberg; Hans Stenlund; Anna-Carin N Wihlbäck; Marie Bixo
Journal:  Psychopharmacology (Berl)       Date:  2016-03-10       Impact factor: 4.530

6.  A post-training intrahippocampal anxiogenic dose of the neurosteroid pregnenolone sulfate impairs passive avoidance retention.

Authors:  E Martín-García; M Pallarés
Journal:  Exp Brain Res       Date:  2008-07-30       Impact factor: 1.972

7.  Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.

Authors:  Helena Hedström; Marie Bixo; Sigrid Nyberg; Olav Spigset; Elisabeth Zingmark; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

Review 8.  Hormonal therapy in traumatic spinal cord injury.

Authors:  Parker E Ludwig; Arun A Patil; Andrea J Chamczuk; Devendra K Agrawal
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

9.  Allopregnanolone impairs episodic memory in healthy women.

Authors:  Kristiina Kask; Torbjörn Bäckström; Lars-Göran Nilsson; Inger Sundström-Poromaa
Journal:  Psychopharmacology (Berl)       Date:  2008-06-13       Impact factor: 4.530

10.  Neurosteroids and GABA-A Receptor Function.

Authors:  Mingde Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.